Learning from the 2001 anthrax attacks: Immunological characteristics

Journal of Infectious Diseases

Volumn 195, Issue 2, 2007, Pages 163-164

  Hadler, James L ^a  

^a CDC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; ANTIBODY PRODUCTION; BIOLOGICAL WARFARE; CELLULAR IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; NOTE; PRIORITY JOURNAL; VACCINATION;

ANTHRAX; ANTHRAX VACCINES; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BACILLUS ANTHRACIS; BIOTERRORISM; HUMANS; IMMUNITY, CELLULAR; INHALATION EXPOSURE; SPORES, BACTERIAL; VACCINATION;

EID: 33846175379     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/510317     Document Type: Note

References (9)

1. Doolan DL, Freilich DA, Brice GT, et al. The US Capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. J Infect Dis 2007; 195:174-84 (in this issue).
2. US Food and Drug Administration. Anthrax vaccine adsorbed (Biothrax). Available at: http://www.fda.gov/cber/label/biopava0131022LB.pdf. Accessed 5 August 2006.
3. Shepard CW, Soriano-Gabarro M, Zell ER, et al. Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerg Infect Dis 2002;8:1124-32.
4. Williams JL, Noviello SS, Griffith KS, et al. Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. Emerg Infect Dis 2002; 8:1133-7.
5. Hsu VP, Lukacs SL, Handzel T, et al. Opening a Bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis 2002; 8:1039-43.
6. Dewan PK, Fry AM, Laserson K, et al. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002; 8:1066-72.
7. Quinn CP, Semenova VA, Elie CM, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002; 8:1103-10.
8. Quinn CP, Dull PM, Semenova V, et al. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis 2004; 190:1228-36.
9. Rhie GE, Roehrl MH, Mourez M, Collier RJ, Mekalanos JJ, Wang JY. A dually active anthrax vaccine that confers protection against both bacilli and toxins. Proc Natl Acad Sci USA 2003; 100:10925-30.